Lecture 11: Ethics of medical research Flashcards

1
Q

Why is ethics important in medical research?

A

Clinical research has the potential for exploitations of human subjects by placing them at risk for the good of others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 7 requirements for ethical research?

(devided into the first and second pillar)

A

First pillar: Acceptability
1. Social of scientific value
2. Scientific validity
3. Fair subject selection
4. Favourable risk-benefit ratio
5. Independent review

Second pillar: informed consent
6. Informed consent

Other..
7. Respect for potential and enrolled subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain social and scientific value

A

Evaluation of a treatment/ intervention/ theory that will improve health and well-being or increase knowledge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain scientific validity

A

Use of accepted scientific principles and methods (including statistical techniques) to produce reliable and valid data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain fair subject selection

A

Selection of subjects so that stigmatized and vulnerable individuals are not targeted for risky research and the rich and socially powerfull are not favoured for potentially beneficial research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain favorable risk-benefit ratio

A
  • Minimization of risks
  • Enhancement of potential benefits
  • Risks to the subject are proportionate to the benefits to the subjects and society
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain independent review

A

Review of the design and research trail, it’s proposed subject population, and risk-benefit ratio by individuals unaffiliated with the research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Informed consent

A

Provision of information to the subject about the purpose, procedures, potential risks, benefits and alternatives, so that the individual can make a voluntary desicion whether to enroll and continue to participate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Respect for potential and enrolled subjects

A

Respect for sibjects by:
1. Permitting withdrawal
2. Protecting privacy (confidentiality)
3. Informing subjects of newly discovered risks/ benefits
4. Informing subjects of results of clinical research
5. Maintaining welfare of subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Responsibility of METC’s? REC’s (pyramid)

A

Ethical review:
- ccmo (1)
- METC’s (15)

Practical issues/ non-WMO:
- Diverse committees (various)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define the WMO and it’s scope

A

The WMO is the law on medical scientific research in human subjects

Medical-scientific research in which subjects are subjected to actions or in which a certain mode of conduct is imposed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Responisbilities of METC members

A

Facilitator
Advisor
Assessor
Protector
Educator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The METC reviews…

A
  • Medical-scientific research in competent subjects
  • Therapeutic research in minors and incompetent subjects
  • Observational research in minors and incompetent subjects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Legally required membership of the METC

A
  1. One or more physicians
  2. Lawyer
  3. ‘Lay member’
  4. Ethicist
  5. Pharmacologist
  6. Methodologist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the central consideration of RECs and CCMO

A

Protection of the subject against risk of medical research without unnecessarily hampering the progress of medical science”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The CCMO reviews..

A

… certain protocols:
- Appeal cases
- Non-therpapeutic intervention-research in minors and incompetent subjects
- Scientific research with embryos
- Sorts of scientific research such as gene therapy, xenotransplantation, research with administration of addictive drugs, research with egg cells and semen, vaccines

17
Q

A methodologically unsound protocol is by definition…

A

Unethical

18
Q

WMO research should meet the informed consent demand, which includes…

A
  • Written consent of the subjects, after written, comprehensive, sufficient information
  • If the subject is incapable of reasonable assessment of the interest at stake, the legal representative needs to consent in writing
19
Q

Emanuel on informed consent

To provide informed consent individuals must be…

A
  • Adequately informed of the purpose, methods, risks, benefits and alternatives to the research
  • Understand the the information and it’s bearing on their own clinical situation
  • Make a voluntary decision whether to participate
20
Q

Problems with informed consent (4)

A
  1. Subjects do not reed the patient information form
  2. Subjects do not understand the information
  3. Subjects understand but do not oversee the consequences
  4. Subjects overestimate the benefits and underestimate the risks (e.g., therapeutic consideration)
21
Q

Takling the problems with informed consent (4)

A
  1. Phases in provision of information (also after having signed the consent form)
  2. Second moment to allow patients to ask questions and at which the physician checks whether the information is understood
  3. Use of different media
  4. Extensive brochures need a summary
22
Q

The prtection model versus the admission model

A

Protection model:
- Protection of incompetent subjects from damage that may be the result of scientific research
- leads to little or no progress in treatment of conditions in incompetent patients

Admission model:
- Incompetent subjects have the right to the best proven treatment. Reliable studies with generalizable results are necessary.
- Implies that minimal risk standard should be abondoned and that incompetent subjects may be subjected to more than the minimal risk

23
Q

Challenges for the future:

A
  • Informed consent as continuing process
  • Developing insight into the perception of subjects participating in medical research
  • Involve subjects into the review process of protocols (to be discussed)
  • Clarity in the proceedings of the research also after approval
  • Harmonization of non-WMO review
  • Openness, also about research that has not led to progress